Tick Insights

Search Icon

Menu Toggle Icon

Skip to content
  • Home
  • Forex
  • CFD Indices
  • CFD Equities
  • Education
  • Events
Tick Insights

Tag: PetroChina

CFD Trading – Buy Petrochina (857.HKE) at $3.50. Stop at $3.30 and Target at $3.80

September 14, 2021September 14, 2021Shueh Ting Wong

PETROCHINA   Stock Code 0857.HKE

Outlook

Price continued to move higher with a long bullish candlestick pattern after resting at the cloud support since the breakout.… Read More

CFD Equities CFD HK Trading Note, PetroChina Leave a comment

CFD Trading – Buy Petrochina (857.HKE) at $2.39. Stop at $2.30 and Target at $2.60.

December 8, 2020Shueh Ting Wong

PETROCHINA   Stock Code 857.HKE

Outlook
Price is now reaching the cloud support, which also coincides with the gap support and the Fibonacci 62% correction point of Oct-Nov 20’s rally.… Read More

CFD Equities CFD HK Trading Note, PetroChina Leave a comment

CFD Trading 24 January 2019

January 24, 2019June 7, 2019Nicholas

PetroChina Stock code 0857.HKE

Outlook

Price has completed its corrective rally with a bearish Engulfing candlestick pattern.… Read More

CFD Equities Keppel Corp, PetroChina Leave a comment

About Us

Tick Insights

UTRADE

Upcoming Webinar

US & HK ETF Available For CFD Trade

Stay Connected

Subscribe to this blog and receive notifications of new posts by email.

Like our Facebook page for the latest updates!

 SG UTRADE

Recent Posts

  • Forex Trading Idea USD/JPY
  • CFD Trading – Buy Sunny Optical (2382.HKE) at $108.80. Stop at $93.30 and Target at $128.70.
  • CFD Trading – Buy Sinopharm (1099.HKE) at $18.50. Stop at $17.60 and Target at $19.90.
  • FX Commentary – US Dollar Holds Near 20-Year High.
  • CFD Trading – Buy Glaxo Smith Kline PLC. (GSK.NYS) @ $44.00. Stop @ $42.10 and Target @ $46.90

Archives

Disclaimer

This information is prepared by personnel in UOB Kay Hian’s Alternative Products Department and is not the product of UOB Kay Hian’s Research Department. It is not a research report and is not intended as such, although a UOB Kay Hian Research report may be referenced as a link or as an attachment hereto.

Opinions expressed herein may differ from the opinions expressed by other areas of UOB Kay Hian, including research. This commentary is provided for information only. Neither the information nor any views expressed constitutes a solicitation for the purchase or sale of any securities or other financial instruments. It is not a personal recommendation, offer or solicitation to buy or sell.

Scroll to Top
 

Loading Comments...